Craig C. Hopkinson, EVP R&D, Chief Medical Officer at Alkermes plc. (ALKS), sold 18,442 shares at $31.50 ($581K) on 2024-12-05, disclosed to the SEC on 2024-12-05.
Scheduled sale ($581k) by EVP R&D, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.50 | 9,221 | $290K | 50.0% |
| 2 | $31.50 | 9,221 | $290K | 50.0% |
| Total | $31.50 avg | 18,442 | $581K | 100% |
| Filing → |
| ALKS | SELL | 2026-07-01 | $464K | — | Filing → |
| ALKS | SELL | 2026-06-01 | $375K | — | Filing → |
| ALKS | SELL | 2026-05-01 | $301K | — | Filing → |